[go: up one dir, main page]

WO1997010258A3 - Anticorps agissant a l'encontre d'epitopes de cadherines desmosomales, exposes a la surface de cellules cancereuses situees en dehors de desmosomes - Google Patents

Anticorps agissant a l'encontre d'epitopes de cadherines desmosomales, exposes a la surface de cellules cancereuses situees en dehors de desmosomes Download PDF

Info

Publication number
WO1997010258A3
WO1997010258A3 PCT/DE1996/001567 DE9601567W WO9710258A3 WO 1997010258 A3 WO1997010258 A3 WO 1997010258A3 DE 9601567 W DE9601567 W DE 9601567W WO 9710258 A3 WO9710258 A3 WO 9710258A3
Authority
WO
WIPO (PCT)
Prior art keywords
cadherines
desmosomal
desmosomes
exposed
antibodies against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/DE1996/001567
Other languages
German (de)
English (en)
Other versions
WO1997010258A2 (fr
Inventor
Werner Franke
Stephan Schaefer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Progen Biotechnik GmbH
Original Assignee
Progen Biotechnik GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Progen Biotechnik GmbH filed Critical Progen Biotechnik GmbH
Priority to EP96943842A priority Critical patent/EP0952987A2/fr
Publication of WO1997010258A2 publication Critical patent/WO1997010258A2/fr
Publication of WO1997010258A3 publication Critical patent/WO1997010258A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

L'invention concerne des anticorps agissant à l'encontre de parties de cadhérines desmosomales, lesdites parties étant exposées à la surface de cellules non liées par des desmosomes. L'invention concerne en outre des procédés de préparation desdits anticorps, ainsi que leur utilisation.
PCT/DE1996/001567 1995-08-23 1996-08-23 Anticorps agissant a l'encontre d'epitopes de cadherines desmosomales, exposes a la surface de cellules cancereuses situees en dehors de desmosomes Ceased WO1997010258A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP96943842A EP0952987A2 (fr) 1995-08-23 1996-08-23 Anticorps agissant a l'encontre d'epitopes de cadherines desmosomales, exposes a la surface de cellules cancereuses situees en dehors de desmosomes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1995131033 DE19531033C2 (de) 1995-08-23 1995-08-23 Antikörper gegen an Oberflächen von Carcinom-Zellen außerhalb von Desmosomen exponierte Epitope desmosomaler Cadherine
DE19531033.0 1995-08-23

Publications (2)

Publication Number Publication Date
WO1997010258A2 WO1997010258A2 (fr) 1997-03-20
WO1997010258A3 true WO1997010258A3 (fr) 1997-07-24

Family

ID=7770208

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE1996/001567 Ceased WO1997010258A2 (fr) 1995-08-23 1996-08-23 Anticorps agissant a l'encontre d'epitopes de cadherines desmosomales, exposes a la surface de cellules cancereuses situees en dehors de desmosomes

Country Status (3)

Country Link
EP (1) EP0952987A2 (fr)
DE (1) DE19531033C2 (fr)
WO (1) WO1997010258A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7481999B2 (en) 1998-05-05 2009-01-27 Adherex Technologies, Inc. Compounds and methods for modulating OB-cadherin-mediated function
AU2003298475A1 (en) 2002-11-14 2004-06-18 Adherex Technologies, Inc. Compounds and methods for modulating desmosomal and atypical cadherin-mediated cell adhesion
CN119192366B (zh) * 2024-11-07 2025-11-04 上海蓝鹊生物医药有限公司 用于检测人dsc2蛋白的抗体和试剂盒
CN119285766B (zh) * 2024-11-07 2025-10-24 上海蓝鹊生物医药有限公司 一种靶向人桥粒糖蛋白2的抗体及试剂盒

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
B. PETERS ET AL.: "Maintenance of cell-type-specific cytoskeletal character in epithelial cells out of epithelial context: Cytokeratins and other cytoskeletal proteins in the rests of Malassez of the periodontal ligament.", DIFFERENTIATION, vol. 59, no. 2, September 1995 (1995-09-01), LONDON, GROSSBRITANNIEN, pages 113 - 126, XP000674532 *
J. LORIMER ET AL.: "Cloning, sequence analysis and expression pattern of mouse desmocollin 2 (DSC2), a cadherin-like adhesion molecule.", MOLECULAR MEMBRANE BIOLOGY, vol. 11, no. 4, October 1994 (1994-10-01), WASHINGTON, DC, VSA, pages 229 - 236, XP000674534 *
S. NATSUGOE ET AL.: "Expression of desmoglein I in squamous cell carcinoma of the esophagus.", JOURNAL OF SURGICAL ONCOLOGY, vol. 57, no. 2, October 1994 (1994-10-01), SAN DIEGO, CA, VSA, pages 105 - 110, XP000674529 *
S. SCHÄFER ET AL.: "Identification of the ubiquitous human desmoglein, Dsg2, and the expression catalogue of the desmoglein subfamily of desmosomal cadherins.", EXPERIMENTAL CELL RESEARCH, vol. 211, no. 2, April 1994 (1994-04-01), NEW YORK, NY, VSA, pages 391 - 399, XP000674513 *
S. SCHÄFER ET AL.: "Immunological identification and characterization of the desmosomal cadherin Dsg2 in coupled and uncoupled epithelial cells and in human tissues.", DIFFERENTIATION, vol. 60, no. 2, May 1996 (1996-05-01), LONDON, GROSSBRITANNIEN, pages 99 - 108, XP000674533 *

Also Published As

Publication number Publication date
DE19531033C2 (de) 1998-01-29
DE19531033A1 (de) 1997-02-27
EP0952987A2 (fr) 1999-11-03
WO1997010258A2 (fr) 1997-03-20

Similar Documents

Publication Publication Date Title
ZA968957B (en) Process for the preparation of dihaloazolopyrimidines.
CY2440B1 (en) Process improvement in the synthesis of N-A3-(3-cyanopyrazolo A1,5-aUpyrimidin-7-yl)phenylU-N-ethyl-acetamide.
EP0636617A3 (fr) Procédé pour la préparation de N-(2-hydroxyéthyle)pipérazine.
ZA964624B (en) Process for the preparation of microcapsule compositions.
AU1218295A (en) Adjuvant for antigens, process for producing the same and its use
AU4032797A (en) Fungal antigens and process for producing the same
AU5686698A (en) Methods for the production of chicken monoclonal antibodies
AU6080794A (en) Antibodies directed against binding-associated epitopes
AU7287598A (en) Process for the conversion of hydrocarbons
WO2000015798A3 (fr) Facteur de croissance transformant beta - 9 mammaliens (ztgfss9)
WO1999065947A3 (fr) Anticorps monoclonaux diriges contre la proteine g3bp, et leurs utilisations
AU5627296A (en) Process for the manufacture of difluoromethane
IL187595A0 (en) Antitumor antibodies, proteins, and uses thereof
AU1052099A (en) Metallic material, brass, and process for producing the same
AU6656996A (en) Zeolites and processes for their manufacture
AU3999785A (en) Laminates, particularly mirror laminates
WO1997010258A3 (fr) Anticorps agissant a l'encontre d'epitopes de cadherines desmosomales, exposes a la surface de cellules cancereuses situees en dehors de desmosomes
AU5058196A (en) Process for the preparation of 1,1-difluoroethane
AU4729396A (en) Process for the preparation of 1,2-benzisothiazolin-3-ones
AU6496094A (en) Tumor-associated antigens recognized by t cells and the uses of these antigens
ZA966452B (en) Process for the preparation of substituted aminocarbonyltriazolinones.
EP0739896A3 (fr) Procédé de préparation de 6-oxo-(6H)-dibenz-(c,e)(1,2)-oxaphosphorines
AU7504691A (en) Monoclonal antibodies against pp4, processes for the preapration thereof and the use thereof
ZA966347B (en) Process for the preparation of 1,4-butenediol.
AU2169797A (en) Improved production of antibodies through the use of antigen antibody complexes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

WWE Wipo information: entry into national phase

Ref document number: 1996943842

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1996943842

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1996943842

Country of ref document: EP